+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Histology And Cytology Market Size, Share & Trends Analysis Report By Type of Examination (Histology, Cytology), By Product (Instruments & Analysis Software System, Consumables & Reagents), By Application, By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 180 Pages
  • March 2025
  • Region: Global
  • Grand View Research
  • ID: 5450203
REQUEST CUSTOMIZATION
Description Jump to:
The global histology and cytology market size is anticipated to reach USD 49.48 billion by 2030. The market is projected to grow at a CAGR of 15.31% from 2025 to 2030. The factors contributing to market growth include increasing demand for early detection of diseases, increased standardization of pathology laboratories, and implementation of immunohistochemistry and innovation in microscopy.

Organizations are focusing on collaborations for the standardization of cytopathology globally, positively impacting market growth. For instance, in November 2022, a novel IARC GICR collaboration center was established in Kenya to advance cancer registration in sub-Saharan Africa via training. The collaborating center focuses on regional training courses and the implementation & development of the CanReg5 software.

Moreover, companies are launching novel and automated instruments for cytology which can be further attributed to the histology and cytology industry growth. For instance, in January 2021, F. Hoffmann-La Roche Ltd launched uPath HER2 (4B5) image analysis and uPath HER2 Dual ISH image analysis-two automated digital pathology algorithms that offer rapid & accurate patient diagnoses in breast cancer.

COVID-19 became a catalyst for changing traditional pathology workflows with the integration of artificial intelligence (AI) and digitalization solutions. During the pandemic, these tools helped and continue to assist in the remote reviewing of pathological cases. Thus, preventing delays in patient care. Companies have reported increasing adoption of digital pathology solutions post-COVID-19.

Histology And Cytology Market Report Highlights

  • The cytology segment accounted for the largest revenue share in 2024 and is expected to continue the trend in the forecast period owing to the integration of computational analytical tools for advancing cytology systems
  • The consumables and reagents segment dominated the histology and cytology industry, attributed to the expanding portfolios of the entities operating in the consumable market. The instruments and analysis software system segment is expected to grow at a substantial CAGR from 2025 to 2030, attributed to the steep increase in the demand for automated histology instruments
  • Drug discovery & designing segment accounted for the highest revenue share in 2024 and is anticipated to grow at the fastest CAGR over the forecast period, owing to the growing importance of cytopathology in disease understanding, further aimed at rapid drug development
  • North America emerged as the highest revenue-generating region in 2024, owing to the prevalence of cancer, the presence of key players, and the developed healthcare infrastructure

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This Report Addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type of Examination
1.2.2. Product
1.2.3. Application
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type of examination outlook
2.2.2. Product outlook
2.2.3. Application outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Histology and Cytology Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising incidence of cancer
3.2.1.2. Technological developments
3.2.1.3. Increase in awareness programs for cervical cancer screening
3.2.2. Market restraint analysis
3.2.2.1. Low sensitivity of cytology tests
3.2.2.2. Conditions required for specimens and problem of mislabeled specimens
3.3. Histology and cytology Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Pricing Analysis
Chapter 4. Histology and cytology Market: Type of Examination Estimates & Trend Analysis
4.1. Global Histology and Cytology Market: Type Of Examination Dashboard
4.2. Global Histology and Cytology Market: Type of Examination Movement Analysis
4.3. Global Histology and Cytology Market by Type of Examination, Revenue
4.4. Histology
4.4.1. Histology market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. By Technique
4.4.2.1. Microscopy
4.4.2.1.1. Microscopy market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.2. Immunohistochemistry
4.4.2.2.1. Immunohistochemistry market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.3. Molecular pathology
4.4.2.3.1. Molecular pathology market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.4. Cryostat & Microtomy
4.4.2.4.1. Cryostat & Microtomy market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Cytology
4.4.3.1. Cytology market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. By Technique
4.4.4.1. Microscopy
4.4.4.1.1. Microscopy market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4.2. Immunohistochemistry
4.4.4.2.1. Immunohistochemistry market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4.3. Molecular pathology
4.4.4.3.1. Molecular pathology market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4.4. Cryostat & Microtomy
4.4.4.4.1. Cryostat & Microtomy market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. By Application
4.4.5.1. Breast Cancer
4.4.5.1.1. Breast Cancer market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5.2. Cervical Cancer
4.4.5.2.1. Cervical Cancer market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5.3. Bladder Cancer
4.4.5.3.1. Bladder Cancer market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5.4. Lung Cancer
4.4.5.4.1. Lung Cancer market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5.5. Other Cancers
4.4.5.5.1. Other Cancer market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Histology and cytology Market: Product Estimates & Trend Analysis
5.1. Global Histology and Cytology Market: Product Dashboard
5.2. Global Histology and Cytology Market: Product Movement Analysis
5.3. Global Histology and Cytology Market by Product, Revenue
5.3.1. Instruments and Analysis Software System
5.3.2. Instruments and analysis software system market estimates and forecasts 2018 to 2030 (USD Million)
5.3.3. Consumable and Reagents
5.3.4. Consumable and reagents market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Histology and cytology Market: Application Estimates & Trend Analysis
6.1. Global Histology and Cytology Market: Application Dashboard
6.2. Global Histology and Cytology Market: Application Movement Analysis
6.3. Global Histology and Cytology Market by Application, Revenue
6.4. Drug Discovery & Designing
6.4.1. Drug discovery & designing market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Clinical Diagnostics
6.5.1. Clinical diagnostics market estimates and forecasts 2018 to 2030 (USD Million)
6.5.2. Point-of-Care (PoC)
6.5.2.1. Point-of-Care (PoC) market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. Non-PoC
6.5.3.1. Non-PoC market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Research
6.6.1. Research market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Histology and cytology Market: Regional Estimates & Trend Analysis by Type of Examination, Product, Application and Methodology
7.1. Regional Dashboard
7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.3. North America
7.3.1. U.S.
7.3.1.1. Key country dynamics
7.3.1.2. Regulatory framework/ reimbursement structure
7.3.1.3. Competitive scenario
7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.3.2. Canada
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/ reimbursement structure
7.3.2.3. Competitive scenario
7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.3.3. Mexico
7.3.3.1. Key country dynamics
7.3.3.2. Regulatory framework/ reimbursement structure
7.3.3.3. Competitive scenario
7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework/ reimbursement structure
7.4.1.3. Competitive scenario
7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. Germany
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. France
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.4.4. Italy
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive scenario
7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.4.5. Spain
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/ reimbursement structure
7.4.5.3. Competitive scenario
7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.4.6. Norway
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/ reimbursement structure
7.4.6.3. Competitive scenario
7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/ reimbursement structure
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.4.8. Denmark
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/ reimbursement structure
7.4.8.3. Competitive scenario
7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. India
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.5.4. Australia
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.5.5. South Korea
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Argentina
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. UAE
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Kuwait
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2024
8.3.4. Hologic, Inc.
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Abbott
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Becton, Dickinson and Company
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. F. Hoffmann-La Roche Ltd
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Merck KGaA
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Thermo Fisher Scientific, Inc.
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Danaher
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Sysmex Corporation
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Trivitron Healthcare
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Koninklijke Philips N.V.
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 North America Histology and cytology market, by region, 2018 - 2030 (USD Million)
Table 3 North America Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
Table 4 North America Histology and cytology market, by product, 2018 - 2030 (USD Million)
Table 5 North America Histology and cytology market, by application, 2018 - 2030 (USD Million)
Table 6 U.S. Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
Table 7 U.S. Histology and cytology market, by application, 2018 - 2030 (USD Million)
Table 8 U.S. Histology and cytology market, by product, 2018 - 2030 (USD Million)
Table 9 Canada Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
Table 10 Canada Histology and cytology market, by application, 2018 - 2030 (USD Million)
Table 11 Canada Histology and cytology market, by product, 2018 - 2030 (USD Million)
Table 12 Mexico Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
Table 13 Mexico Histology and cytology market, by application, 2018 - 2030 (USD Million)
Table 14 Mexico Histology and cytology market, by product, 2018 - 2030 (USD Million)
Table 15 Europe Histology and cytology market, by region, 2018 - 2030 (USD Million)
Table 16 Europe Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
Table 17 Europe Histology and cytology market, by application, 2018 - 2030 (USD Million)
Table 18 Europe Histology and cytology market, by product, 2018 - 2030 (USD Million)
Table 19 Germany Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
Table 20 Germany Histology and cytology market, by application, 2018 - 2030 (USD Million)
Table 21 Germany Histology and cytology market, by product, 2018 - 2030 (USD Million)
Table 22 UK Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
Table 23 UK Histology and cytology market, by application, 2018 - 2030 (USD Million)
Table 24 UK Histology and cytology market, by product, 2018 - 2030 (USD Million)
Table 25 France Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
Table 26 France Histology and cytology market, by application, 2018 - 2030 (USD Million)
Table 27 France Histology and cytology market, by product, 2018 - 2030 (USD Million)
Table 28 Italy Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
Table 29 Italy Histology and cytology market, by application, 2018 - 2030 (USD Million)
Table 30 Italy Histology and cytology market, by product, 2018 - 2030 (USD Million)
Table 31 Spain Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
Table 32 Spain Histology and cytology market, by application, 2018 - 2030 (USD Million)
Table 33 Spain Histology and cytology market, by product, 2018 - 2030 (USD Million)
Table 34 Denmark Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
Table 35 Denmark Histology and cytology market, by application, 2018 - 2030 (USD Million)
Table 36 Denmark Histology and cytology market, by product, 2018 - 2030 (USD Million)
Table 37 Sweden Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
Table 38 Sweden Histology and cytology market, by application, 2018 - 2030 (USD Million)
Table 39 Sweden Histology and cytology market, by product, 2018 - 2030 (USD Million)
Table 40 Norway Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
Table 41 Norway Histology and cytology market, by application, 2018 - 2030 (USD Million)
Table 42 Norway Histology and cytology market, by product, 2018 - 2030 (USD Million)
Table 43 Asia Pacific Histology and cytology market, by region, 2018 - 2030 (USD Million)
Table 44 Asia Pacific Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
Table 45 Asia Pacific Histology and cytology market, by application, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Histology and cytology market, by product, 2018 - 2030 (USD Million)
Table 47 China Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
Table 48 China Histology and cytology market, by application, 2018 - 2030 (USD Million)
Table 49 China Histology and cytology market, by product, 2018 - 2030 (USD Million)
Table 50 Japan Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
Table 51 Japan Histology and cytology market, by application, 2018 - 2030 (USD Million)
Table 52 Japan Histology and cytology market, by product, 2018 - 2030 (USD Million)
Table 53 India Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
Table 54 India Histology and cytology market, by application, 2018 - 2030 (USD Million)
Table 55 India Histology and cytology market, by product, 2018 - 2030 (USD Million)
Table 56 South Korea Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
Table 57 South Korea Histology and cytology market, by application, 2018 - 2030 (USD Million)
Table 58 South Korea Histology and cytology market, by product, 2018 - 2030 (USD Million)
Table 59 Australia Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
Table 60 Australia Histology and cytology market, by application, 2018 - 2030 (USD Million)
Table 61 Australia Histology and cytology market, by product, 2018 - 2030 (USD Million)
Table 62 Thailand Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
Table 63 Thailand Histology and cytology market, by application, 2018 - 2030 (USD Million)
Table 64 Thailand Histology and cytology market, by product, 2018 - 2030 (USD Million)
Table 65 Latin America Histology and cytology market, by region, 2018 - 2030 (USD Million)
Table 66 Latin America Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
Table 67 Latin America Histology and cytology market, by application, 2018 - 2030 (USD Million)
Table 68 Latin America Histology and cytology market, by product, 2018 - 2030 (USD Million)
Table 69 Brazil Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
Table 70 Brazil Histology and cytology market, by application, 2018 - 2030 (USD Million)
Table 71 Brazil Histology and cytology market, by product, 2018 - 2030 (USD Million)
Table 72 Argentina Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
Table 73 Argentina Histology and cytology market, by application, 2018 - 2030 (USD Million)
Table 74 Argentina Histology and cytology market, by product, 2018 - 2030 (USD Million)
Table 75 MEA Histology and cytology market, by region, 2018 - 2030 (USD Million)
Table 76 MEA Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
Table 77 MEA Histology and cytology market, by application, 2018 - 2030 (USD Million)
Table 78 MEA Histology and cytology market, by product, 2018 - 2030 (USD Million)
Table 79 South Africa Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
Table 80 South Africa Histology and cytology market, by application, 2018 - 2030 (USD Million)
Table 81 South Africa Histology and cytology market, by product, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia Histology and cytology market, by application, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia Histology and cytology market, by product, 2018 - 2030 (USD Million)
Table 85 UAE Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
Table 86 UAE Histology and cytology market, by application, 2018 - 2030 (USD Million)
Table 87 UAE Histology and cytology market, by product, 2018 - 2030 (USD Million)
Table 88 Kuwait Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
Table 89 Kuwait Histology and cytology market, by application, 2018 - 2030 (USD Million)
Table 90 Kuwait Histology and cytology market, by product, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Histology and cytology market: market outlook
Fig. 14 Histology and cytology competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Histology and cytology market driver impact
Fig. 18 Histology and cytology market restraint impact
Fig. 19 Histology and cytology market: Type of examination movement analysis
Fig. 20 Histology and cytology market: Type of examination outlook and key takeaways
Fig. 21 Histology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Microscopy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Immunohistochemistry market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Molecular pathology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Cryostat & microtomy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Cytology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Microscopy estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Immunohistochemistry market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Molecular pathology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Cryostat & microtomy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Cervical Cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Breast Cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Bladder Cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Lung Cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Other Cancers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Histology and cytology market: Product movement analysis
Fig. 37 Histology and cytology market: Product outlook and key takeaways
Fig. 38 Instruments and analysis software system market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Consumable and reagents market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Histology and cytology market: Application movement analysis
Fig. 41 Histology and cytology market: Application outlook and key takeaways
Fig. 42 Drug discovery & designing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Clinical diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Point-of-Care (PoC) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Non-PoC market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Research market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Global Histology and Cytology market: Regional movement analysis
Fig. 48 Global Histology and Cytology market: Regional outlook and key takeaways
Fig. 49 Global Histology and Cytology market share and leading players
Fig. 50 North America, by country
Fig. 51 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 U.S. key country dynamics
Fig. 53 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Canada key country dynamics
Fig. 55 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Mexico key country dynamics
Fig. 57 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 UK key country dynamics
Fig. 60 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Germany key country dynamics
Fig. 62 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 France key country dynamics
Fig. 64 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Italy key country dynamics
Fig. 66 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Spain key country dynamics
Fig. 68 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Denmark key country dynamics
Fig. 70 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Sweden key country dynamics
Fig. 72 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Norway key country dynamics
Fig. 74 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 China key country dynamics
Fig. 77 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Japan key country dynamics
Fig. 79 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 80 India key country dynamics
Fig. 81 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 Thailand key country dynamics
Fig. 83 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 84 South Korea key country dynamics
Fig. 85 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Australia key country dynamics
Fig. 87 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 88 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 89 Brazil key country dynamics
Fig. 90 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 91 Argentina key country dynamics
Fig. 92 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 93 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 94 South Africa key country dynamics
Fig. 95 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 96 Saudi Arabia key country dynamics
Fig. 97 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 98 UAE key country dynamics
Fig. 99 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 100 Kuwait key country dynamics
Fig. 101 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 102 Market share of key market players- Histology and cytology market

Companies Mentioned

  • Hologic, Inc.
  • Abbott
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche Ltd
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Danaher
  • Sysmex Corporation
  • Trivitron Healthcare
  • Koninklijke Philips N.V.

Table Information

Report AttributeDetails
No. of Pages180
PublishedMarch 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 21.13 Billion
Forecasted Market Value ( USD ) by 2030 $ 49.48 Billion
Compound Annual Growth Rate15.3%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Histology and Cytology - Global Strategic Business Report - Product Image

Histology and Cytology - Global Strategic Business Report

  • Report
  • 191 Pages
  • Global
From
Histology and Cytology Market Report by Product, Type of Examination, Test Type, Application, and Region 2025-2033 - Product Image

Histology and Cytology Market Report by Product, Type of Examination, Test Type, Application, and Region 2025-2033

  • Report
  • 139 Pages
  • Global
From
Histology and Cytology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Histology and Cytology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 188 Pages
  • Global
From
Histology and Cytology Market Report 2025 - Product Image

Histology and Cytology Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Histology & Cytology Market - Global Forecast 2025-2032 - Product Image

Histology & Cytology Market - Global Forecast 2025-2032

  • Report
  • 199 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.